Product Information
FEMRING 0.05 MG/DAY VAG RING is a brand product labeled by Millicent US, Inc., priced at $866.0693 per EA under NDC 72495020105. Its NADAC has been published 393 times since Mar 27, 2019.
FDA first approved this application on Mar 20, 2003.
Strength
.05 mg/d
Manufacturer
Millicent US, Inc.NDC
72495020105
Classification
Brand
Dosage Form
RING
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
ESTRADIOL ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA021367FDA Approved
3/20/2003
On Market Since
12/10/2018
Pharmacological Classes
Price Statistics
The NADAC for FEMRING 0.05 MG/DAY VAG RING has been published 393 times since Mar 27, 2019, and over the history we have for it it has risen 102.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $866.0693 per EA |
|---|---|
| All-time high | $869.5750 (Jun 10, 2026) |
| All-time low | $427.1760 (Mar 27, 2019) |
| 52-week high | $869.5750 |
| 52-week low | $795.1057 |
| Median price | $664.7211 |
| Average price | $647.3813 |
| Largest weekly change | +9.5% (Jan 1, 2020) |
| Weeks tracked | 393 |
| Tracking since | Mar 27, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the estradiol acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Millicent US, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
estradiol acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FEMRING 0.05 MG/DAY VAG RING?
The current National Average Drug Acquisition Cost (NADAC) for FEMRING 0.05 MG/DAY VAG RING, manufactured by Millicent US, Inc., is $866.0693 per EA (NDC 72495020105), effective Sep 30, 2026.
How has the price of FEMRING 0.05 MG/DAY VAG RING changed over time?
Over the history we have for it, the NADAC for FEMRING 0.05 MG/DAY VAG RING has risen 102.7%. It has been tracked across 393 weekly CMS publications since Mar 27, 2019.
What are the highest and lowest recorded NADAC prices for FEMRING 0.05 MG/DAY VAG RING?
Since Mar 27, 2019, the NADAC for FEMRING 0.05 MG/DAY VAG RING has ranged from a low of $427.1760 (Mar 27, 2019) to a high of $869.5750 (Jun 10, 2026), with a median of $664.7211 per EA.
Are there cheaper alternatives to FEMRING 0.05 MG/DAY VAG RING?
No other NADAC-published product currently shares the active ingredient and strength of FEMRING 0.05 MG/DAY VAG RING in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FEMRING 0.05 MG/DAY VAG RING?
FEMRING 0.05 MG/DAY VAG RING (NDC 72495020105) is labeled by Millicent US, Inc., and CMS classifies it as a brand product.